NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $78.65 -0.60 (-0.76%) Closing price 03:59 PM EasternExtended Trading$78.62 -0.03 (-0.03%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Solventum Stock (NYSE:SOLV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Solventum alerts:Sign Up Key Stats Today's Range$76.99▼$79.2550-Day Range$73.41▼$82.5052-Week Range$62.38▼$88.20Volume809,974 shsAverage Volume1.43 million shsMarket Capitalization$13.62 billionP/E Ratio9.64Dividend YieldN/APrice Target$81.91Consensus RatingHold Company Overview Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota. Read More Solventum Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks71st Percentile Overall ScoreSOLV MarketRank™: Solventum scored higher than 71% of companies evaluated by MarketBeat, and ranked 421st out of 1,682 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingHold Consensus RatingSolventum has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on no strong buy ratings, 6 buy ratings, 6 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Solventum is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageSolventum has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth7.90% Earnings GrowthEarnings for Solventum are expected to grow by 7.90% in the coming year, from $6.58 to $7.10 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Solventum is 9.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.14.Price to Earnings Ratio vs. SectorThe P/E ratio of Solventum is 9.64, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.00.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.25. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSolventum has a P/B Ratio of 2.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Solventum's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.91% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 3.11, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Solventum has recently decreased by 7.76%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.74 News SentimentSolventum has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Solventum this week, compared to 5 articles on an average week.Search Interest2 people have searched for SOLV on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows3 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have not sold or bought any company stock.Percentage Held by Insiders0.24% of the stock of Solventum is held by insiders.Percentage Held by InstitutionsSolventum has minimal institutional ownership at this time.Read more about Solventum's insider trading history. Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SOLV Stock News HeadlinesSolventum Names New Chief Accounting OfficerJuly 20 at 5:11 PM | tipranks.comSolventum Corporation (SOLV) Stock Major Holders - Yahoo FinanceJuly 18 at 8:20 AM | finance.yahoo.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.July 21 at 1:00 AM | Banyan Hill Publishing (Ad)Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026July 15, 2026 | prnewswire.comSolventum Corporation (NYSE:SOLV) Given Consensus Recommendation of "Hold" by AnalystsJuly 14, 2026 | americanbankingnews.comSolving A Lackluster Growth Outlook Should Be Solventum's Next PriorityJuly 10, 2026 | seekingalpha.com2 S&P 500 stocks to own for decades and 1 we questionJuly 7, 2026 | msn.comSolventum Corporation SOLV Stock Forecast & Price TargetJuly 3, 2026 | finance.yahoo.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $79.25 at the start of the year. Since then, SOLV stock has decreased by 0.8% and is now trading at $78.65. How were Solventum's earnings last quarter? Solventum Corporation (NYSE:SOLV) issued its quarterly earnings results on Tuesday, May, 5th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.35 by $0.13. Solventum's quarterly revenue was down 3.0% compared to the same quarter last year. Read the conference call transcript. How will Solventum's stock buyback program work? Solventum's Board of Directors initiated a stock buyback program on Thursday, November 20th 2025, which allows the company to repurchase $1,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 7.5% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's board believes its stock is undervalued. Who are Solventum's major shareholders? Solventum's top institutional investors include Wedge Capital Management L L P NC (0.22%), Handelsbanken Fonder AB (0.03%), Czech National Bank (0.02%) and Focus Financial Network Inc. (0.01%). View institutional ownership trends. How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Solventum own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AUO (AUOTY). Company Calendar Last Earnings5/05/2026Today7/21/2026Next Earnings (Estimated)8/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 SOLV's financial health is in the Green zone, according to TradeSmith. SOLV has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous SymbolNYSE:SOLV CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees20,000Year Founded2023Price Target and Rating Average Price Target for Solventum$81.91 High Price Target$100.00 Low Price Target$50.00 Potential Upside/Downside+4.1%Consensus RatingHold Rating Score (0-4)2.38 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)$8.16 Trailing P/E Ratio9.64 Forward P/E Ratio11.95 P/E Growth1.25Net Income$1.56 billion Net Margins17.33% Pretax Margin20.47% Return on Equity23.51% Return on Assets7.63% Debt Debt-to-Equity Ratio0.96 Current Ratio1.07 Quick Ratio0.75 Sales & Book Value Annual Sales$8.33 billion Price / Sales1.64 Cash Flow$8.69 per share Price / Cash Flow9.05 Book Value$29.11 per share Price / Book2.70Miscellaneous Outstanding Shares173,180,000Free Float172,759,000Market Cap$13.62 billion OptionableOptionable Beta0.66 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NYSE:SOLV) was last updated on 7/21/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
